Videos

Mary Beth Yackey, OD, and Michael Javaheri, MD, share their perspectives on the modernization of geographic atrophy identification and treatment.

Deborah Ristvedt, DO, details her CIME 2024 presentation on new glaucoma management options, led alongside Inder Paul Singh, MD, Arsham Sheybani, MD, and Melissa Tawa, OD, FAAO.

David A. Berntsen, OD, PhD, FAAO, talks through his 2024 ARVO presentation on the BLINK2 study and the findings on axial growth after discontinuing soft multifocal contact lens wear.

Marc Bloomenstein, OD, FAAO, discusses how optometrists can proactively manage Demodex blepharitis by regularly examining eyelids, diagnosing the condition early, and offering treatments to effectively eradicate the mites and prevent future complications.

James A Katz, MD, details treatment options for Demodex blepharitis, from tea tree oil to XDEMVY.

The Patient Whisperers Cofounders Lauren Weaver and Christine Scarlett gave their keynote presentation "The Secret to Crazy Growth: Defining Your Identity on Social Media," at the 2024 Controversies in Modern Eye Care meeting May 4 in Los Angeles, California.

The company's ONE by ONE and Biotrue Eye Care Recycling programs have collected over 84 million units or over 500,000 pounds, of used contact lenses, eye care and lens care materials in the US.

Neda Shamie, MD, previews a collaborative day packed with guest speakers, discussions on advanced patient care, and hands-on labs.

Controversies in Modern Eye Care cochair Arjan Hura, MD, details new expansions to the conference's schedule, which include discussions on retina gene therapies, corneal endothelial diseases, and oculoplastics.

Michele Andrews, OD, vice president of professional and government affairs for CooperVision, and Terri A. Gossard, OD, MS, member of the AOA board of trustees, sat down with Optometry Times to discuss the goals and tactics of The Myopia Collective.

Before the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment.

Bryan Wilson, executive director of medical affairs at Genentech, details why Birmingham, Alabama was chosen as the community to study the effects of diabetic eye disease among African Americans in a new manuscript from the ADA and Genentech.

The manuscript, "Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama," highlights the burden of diabetic eye disease in Alabama, as well as strategies that target racial health disparities within that population.

Jill Saxon, OD, FAAO, chats about eye health safety for the upcoming total solar eclipse on April 8, 2024, and how Bausch + Lomb is celebrating the celestial event.

Davis Corley, CEO of Neurolens, outlines the importance a new study that show statistically significant improvement of headaches with the use of Neurolens.

Charles Leclercq, CEO of ARxVision, outlines the conception of ARxVIsion's collaboration with Seeing AI and NaviLens apps, and details the popular uses for the headset so far.

Rebecca Alexander, LCSW-R, MPH, has been gradually losing both her vision and hearing since she was a teenager due to Usher syndrome type 3. She discusses the importance of making practice accessible for those with vision loss in an exclusive interview.

Ben Gaddie, OD, FAAO closes this series discussing his treatment protocol for patients with demodex blepharitis, reflecting on the major treatment advancements that can quickly alleviate patient symptoms.

Ben Gaddie, OD, FAAO presents the second patient case of a 66-year-old white female with eye dryness and irritation. Though she was not previously treated for demodex blepharitis, he demonstrates how it was the root cause of many symptoms she experienced.

Ben Gaddie, OD, FAAO discusses demodex blepharitis, common symptoms, and prior treatment options that struggled to control their reproductive cycle.

Ben Gaddie, OD, FAAO presents the first patient case of a 53-year-old white female who has tried many treatments. Gaddie highlights his treatment approach and how the patient saw improvements within eight weeks.

March 23 is World Optometry Day, and we asked members of the optometric community one question: How does optometry make the world a better place?

With The Ohio State University College of Optometry in the path of totality for this year's total solar eclipse, 1 optometry school has prepared its alumni, students, and doctors to share information with the public.

Nicholas Gilberg, OD, with EssilorLuxxotica's Leonardo team walks through the basics of the education software that can be implemented in any practice.

Laura Periman, MD, talks through what was gained from the conference, from becoming acquainted with new technological advancements to renewing passion for dry eye care.

Optometrists are often the first to notice ocular adverse effects from systemic medication. When should optometrists reach out to prescribing doctors?

Scott Moscow, OD, talks his practice's contact lens "test-driving" option and how to get patients on board with trying out new corrective eyewear.

At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.

Alysse Henkel, vice president of research and inSights at The Vision Council, details recent research conducted by the company regarding consumer purchasing habits and trends.